Reese V - Search Results

1

Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.

Carrigy NB, Larsen SE, Reese V, Pecor T, Harrison M, Kuehl PJ, Hatfull GF, Sauvageau D, Baldwin SL, Finlay WH, Coler RN, Vehring R. Carrigy NB, et al. Among authors: reese v. Antimicrob Agents Chemother. 2019 Sep 9;63(12):e00871-19. doi: 10.1128/AAC.00871-19. Epub 2019 Sep 16. Antimicrob Agents Chemother. 2019. PMID: 31527037 Free PMC article.

2

Mycobacterium tuberculosis Rv0198c, a putative matrix metalloprotease is involved in pathogenicity.

Muttucumaru DG, Smith DA, McMinn EJ, Reese V, Coler RN, Parish T. Muttucumaru DG, et al. Among authors: reese v. Tuberculosis (Edinb). 2011 Mar;91(2):111-6. doi: 10.1016/j.tube.2010.11.010. Epub 2011 Jan 8. Tuberculosis (Edinb). 2011. PMID: 21216669

3

The importance of adjuvant formulation in the development of a tuberculosis vaccine.

Baldwin SL, Bertholet S, Reese VA, Ching LK, Reed SG, Coler RN. Baldwin SL, et al. J Immunol. 2012 Mar 1;188(5):2189-97. doi: 10.4049/jimmunol.1102696. Epub 2012 Jan 30. J Immunol. 2012. PMID: 22291184 Free PMC article.

4

Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.

Coler RN, Bertholet S, Pine SO, Orr MT, Reese V, Windish HP, Davis C, Kahn M, Baldwin SL, Reed SG. Coler RN, et al. Among authors: reese v. J Infect Dis. 2013 Apr 15;207(8):1242-52. doi: 10.1093/infdis/jis425. Epub 2012 Aug 13. J Infect Dis. 2013. PMID: 22891286 Free PMC article.

5

Chitin microneedles for an easy-to-use tuberculosis skin test.

Jin J, Reese V, Coler R, Carter D, Rolandi M. Jin J, et al. Among authors: reese v. Adv Healthc Mater. 2014 Mar;3(3):349-53. doi: 10.1002/adhm.201300185. Epub 2013 Aug 26. Adv Healthc Mater. 2014. PMID: 23983170

6

The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative.

Baldwin SL, Reese V, Granger B, Orr MT, Ireton GC, Coler RN, Reed SG. Baldwin SL, et al. Among authors: reese v. Clin Vaccine Immunol. 2014 Sep;21(9):1309-13. doi: 10.1128/CVI.00372-14. Epub 2014 Jul 16. Clin Vaccine Immunol. 2014. PMID: 25030053 Free PMC article.

7

Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.

Orr MT, Ireton GC, Beebe EA, Huang PW, Reese VA, Argilla D, Coler RN, Reed SG. Orr MT, et al. J Immunol. 2014 Sep 15;193(6):2911-8. doi: 10.4049/jimmunol.1401103. Epub 2014 Aug 1. J Immunol. 2014. PMID: 25086172 Free PMC article.

8

Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.

Orr MT, Windish HP, Beebe EA, Argilla D, Huang PW, Reese VA, Reed SG, Coler RN. Orr MT, et al. J Infect Dis. 2015 Aug 1;212(3):495-504. doi: 10.1093/infdis/jiv055. Epub 2015 Jan 30. J Infect Dis. 2015. PMID: 25637347 Free PMC article.

9

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.

Orr MT, Beebe EA, Hudson TE, Argilla D, Huang PW, Reese VA, Fox CB, Reed SG, Coler RN. Orr MT, et al. Vaccine. 2015 Nov 27;33(48):6570-8. doi: 10.1016/j.vaccine.2015.10.115. Epub 2015 Nov 3. Vaccine. 2015. PMID: 26541135 Free PMC article.

10

Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.

Baldwin SL, Reese VA, Huang PW, Beebe EA, Podell BK, Reed SG, Coler RN. Baldwin SL, et al. Clin Vaccine Immunol. 2015 Dec 9;23(2):137-47. doi: 10.1128/CVI.00458-15. Print 2016 Feb. Clin Vaccine Immunol. 2015. PMID: 26656121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page